Quick Order Cart

Cat. No. ARG1320

MTMR12 Knockout Raji Polyclonal Cells

  • Product Type:

    Polyclonal Cell Population

  • Species:

    Homo sapiens (Human)

  • Tissue Source:

    Bone

  • Disease:

    Burkitt lymphoma

CRISPR/Cas9-edited polyclonal Raji B lymphocyte population lacking MTMR12, a pseudophosphatase adaptor that scaffolds the MTM1 phosphatase complex to control endosomal and autophagosomal PI3P pools. MTMR12 interacts with VPS34 and Beclin 1 and is regulated by mTORC1 and AMPK. Ideal for autophagy flux assays (LC3/p62 Western blotting, bafilomycin A1 treatment), endosomal immunofluorescence, and PI3P lipid ELISA in an EBV-positive Burkitt lymphoma background. Enables mechanistic studies of phosphoinositide signaling, autophagy in B-cell lymphoma, and endolysosomal trafficking. This model aids dissection of MTMR12-dependent autophagy and endosomal functions relevant to lymphoma and neurodegeneration research.

Inquire Now

In stock

Ships next business day


Ask a Question

Shipping Info:

Cryopreserved in vials and shipped on dry ice


Disclaimer:

For Research Use Only

  • Characteristics

    Host Cell

    Raji

    Cell Type

    B cell line

    Sex of Donor

    Male

    Age

    11 years

    Derived From Site

    In situ; Maxilla

    Gene Name

    MTMR12

    Gene Identifier

    NCBI Gene ID 54545

    Morphology

    Lymphoblast-like

    Growth Mode

    Suspension

    Storage

    Liquid nitrogen (LN2)

  • Culture Conditions

    Growth medium

    RPMI 1640

    Supplement(s)

    10% Fetal Bovine Serum, 1% Penicillin-Streptomycin Solution

    Temperature

    37°C

    Atmosphere

    5% CO₂

  • Quality Control

    Sterility testing

    The bacterial, yeast, and fungi are not detected in these cells by daily monitor.

    Mycoplasma testing

    Negative for mycoplasma through PCR analysis

  • Disclaimer

    Intended Use

    This product is intended for laboratory in vitro use only. lt is not intended for diagnostic, therapeutic, or clinical applications.

    Disclaimer

    Ascent Research endeavors to provide accurate and up-to-date product information. However, no warranties or representations are made regarding its completeness or reliability. References to scientific literature and patents are for informational purposes only, and the customer assumes sole responsibility for verifying their accuracy.

    By accepting this product, the customer acknowledges and agrees to assume all risks associated with its receipt, handling, storage, disposal, and use, including compliance with all applicable safety and environmental regulations and precautions. Relevant laws, regulations, and ethical guidelines must be followed in conducting any research, modifications, or derivatives derived from this product.

    This product is provided "AS IS", and except as expressly stated herein, Ascent Research disclaims all other warranties, express or implied. Under no circumstances shall Ascent Research, its affiliates, or representatives be liable for indirect, incidental, consequential, or punitive damages arising from the use of this material. While Ascent Research employs rigorous quality control measures, we shall not be held responsible for damages resulting from misidentification or misinterpretation of the provided materials.

Description

The MTMR12 Knockout Raji Polyclonal Cells product comprises a CRISPR/Cas9-edited polyclonal population of Raji B lymphocytes harboring a targeted disruption of the MTMR12 gene. This loss-of-function model provides a genetically defined system for investigating the roles of the MTMR12 pseudophosphatase adaptor in endosomal phosphoinositide metabolism and autophagy regulation. The polyclonal knockout format provides a diverse allelic pool for robust functional analyses without clonal selection bias. These suspension cells retain parental Raji characteristics with abolished MTMR12 expression.

Raji cells are an Epstein-Barr virus (EBV)-positive human B-lymphocyte line derived from a Burkitt lymphoma patient. They retain germinal center B-cell features and active B-cell receptor signaling. EBV latent gene expression modulates apoptosis and proliferation, establishing Raji as a standard lymphoma and B-cell immunology model. The hematopoietic origin and robust growth kinetics of Raji cells facilitate diverse experimental manipulations, including genetic knockout studies.

MTMR12 is a catalytically inactive pseudophosphatase scaffolding the MTM1 phosphatase complex on endosomal and autophagosomal membranes. It directly interacts with MTM1, Beclin 1, and the lipid kinase VPS34 to spatially regulate phosphatidylinositol 3-phosphate (PI3P) pools. Upstream signals from VPS34, mTORC1, and AMPK modulate its scaffolding function, which directs MTM1-mediated PI3P dephosphorylation and controls downstream WIPI2 recruitment and LC3 lipidation. This coordinates autophagosome maturation and endosomal trafficking in response to nutrient and stress cues.

In the Raji lymphoma background, disruption of MTMR12 perturbs the PI3P-dependent endosomal sorting and autophagy pathways that are often dysregulated in B-cell malignancies. EBV-associated lymphomas exhibit altered autophagy and endocytic signaling, processes in which MTMR12 is a critical node. This knockout model thus enables dissection of how pseudophosphatase adaptor-dependent PI3P metabolism influences lymphoma cell growth, survival, and response to microenvironmental cues. The model is also relevant for studying mechanisms underlying centronuclear myopathy and neurodegenerative disorders where MTMR12 dysfunction has been implicated.

This product enables autophagy flux assays (LC3/p62 Western blotting and bafilomycin A1 treatment), endosomal marker immunofluorescence, and PI3P lipid ELISA. Co-immunoprecipitation of the MTM1?CBeclin 1?CVPS34 complex and flow cytometric apoptosis assays are also applicable. Researchers focusing on phosphoinositide signaling, autophagy regulation in B cells, or endolysosomal pathway analysis will find this model a valuable tool for genetic perturbation studies. For further technical details or ordering information, please contact Ascent Research.

Reset Password

    Reach Us Questions? Click Me Here!

    Fill out the form below and a member of our team will contact you shortly!

    *Required field



      Reach Us

      Fill out the form below and a member of our team will contact you shortly!

      *Required field

      Product Inquiry (Optional)